AVBP logo

ArriVent BioPharma (AVBP)

Profile

Full Name

ArriVent BioPharma, Inc.

Ticker Symbol

AVBP

Exchange

NASDAQ

Country

United States

IPO

January 26, 2024

Indexes

Not included

Employees

52

Key Details

Price

$18.49

Market Cap

$628.96M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

-

Annual EPS

-$2.56(-17.99% YoY)

PE Ratio

-

Next earnings date

May 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Mar 20, 25 B. Riley Securities
Buy
Mar 10, 25 Guggenheim
Buy
Mar 7, 25 HC Wainwright & Co.
Buy
Jan 22, 25 HC Wainwright & Co.
Buy
Nov 15, 24 HC Wainwright & Co.
Buy
Sep 11, 24 Citigroup
Buy
Sep 10, 24 Oppenheimer
Outperform
Sep 10, 24 HC Wainwright & Co.
Buy
Sep 10, 24 Goldman Sachs
Buy
Aug 16, 24 HC Wainwright & Co.
Buy

Institutional Ownership

  • What is the ticker symbol for ArriVent BioPharma?
  • Does ArriVent BioPharma pay dividends?
  • What sector is ArriVent BioPharma in?
  • What industry is ArriVent BioPharma in?
  • What country is ArriVent BioPharma based in?
  • When did ArriVent BioPharma go public?
  • Is ArriVent BioPharma in the S&P 500?
  • Is ArriVent BioPharma in the NASDAQ 100?
  • Is ArriVent BioPharma in the Dow Jones?
  • When was ArriVent BioPharma's last earnings report?
  • When does ArriVent BioPharma report earnings?
  • Should I buy ArriVent BioPharma stock now?

What is the ticker symbol for ArriVent BioPharma?

The ticker symbol for ArriVent BioPharma is NASDAQ:AVBP

Does ArriVent BioPharma pay dividends?

No, ArriVent BioPharma does not pay dividends

What sector is ArriVent BioPharma in?

ArriVent BioPharma is in the Healthcare sector

What industry is ArriVent BioPharma in?

ArriVent BioPharma is in the Biotechnology industry

What country is ArriVent BioPharma based in?

ArriVent BioPharma is headquartered in United States

When did ArriVent BioPharma go public?

ArriVent BioPharma's initial public offering (IPO) was on January 26, 2024

Is ArriVent BioPharma in the S&P 500?

No, ArriVent BioPharma is not included in the S&P 500 index

Is ArriVent BioPharma in the NASDAQ 100?

No, ArriVent BioPharma is not included in the NASDAQ 100 index

Is ArriVent BioPharma in the Dow Jones?

No, ArriVent BioPharma is not included in the Dow Jones index

When was ArriVent BioPharma's last earnings report?

ArriVent BioPharma's most recent earnings report was on Mar 3, 2025

When does ArriVent BioPharma report earnings?

The next expected earnings date for ArriVent BioPharma is May 30, 2025

Should I buy ArriVent BioPharma stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page